Scarica l'app Stockscreener
61.73
3.42%
2.04
Dopo l'orario di chiusura:
61.00
-0.73
-1.18%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Storia dei dividendi
Royalty Pharma Plc Borsa (RPRX) Ultime notizie
Royalty Pharma EVP Christopher Hite Sells 100,000 Shares and Donates 16,800 Shares to Charity - kalkinemedia.com
Royalty Pharma (NASDAQ:RPRX) EVP Christopher Hite Sells 100,000 Shares of Stock - MarketBeat
Royalty Pharma (NASDAQ: RPRX) exec sells 100K shares, donates stock - Stock Titan
Royalty Pharma (NASDAQ:RPRX) Sets New 1-Year HighHere's What Happened - MarketBeat
Royalty Pharma stock hits all-time high at 60.44 USD - Investing.com
Royalty Pharma stock hits all-time high at 60.44 USD By Investing.com - Investing.com Nigeria
Commerzbank Aktiengesellschaft FI Invests $1.20 Million in Royalty Pharma PLC $RPRX - MarketBeat
How Investors Are Reacting To Royalty Pharma (RPRX) Buying Rusfertide Royalties From Zealand Pharma - simplywall.st
Royalty Pharma (NASDAQ: RPRX) holder plans multi-million share sale - Stock Titan
Royalty Pharma EVP & CFO Terrance Coyne sells $645k in shares - Investing.com South Africa
Royalty Pharma (RPRX) CFO sells 11,002 shares in trading plan - Stock Titan
LYNWOOD PRICE CAPITAL MANAGEMENT LP's Royalty Pharma PLC(RPRX) Holding History - GuruFocus
Royalty Pharma Plc (RPRX) Stock Analysis: Unpacking A 10.49% Potential Upside - DirectorsTalk Interviews
S&CO Inc. Buys Shares of 358,302 Royalty Pharma PLC $RPRX - MarketBeat
Here’s How Much You Would Have Made Owning Royalty Pharma Stock In The Last 10 Years - Benzinga
Royalty Pharma (RPRX) Following Mixed Earnings Still Looks Close To Fair Value - Sahm
Royalty Pharma plc (RPRX) vs. AstraZeneca PLC (AZN): Which Biopharma Model Offers the Better Growth Story? - Yahoo Finance
Royalty Pharma (RPRX) holder TPC RP EPA1 LLC eyes 11,002-share stock sale - Stock Titan
Royalty Pharma Locks in $100M Zealand Pharma Funding Pact for Blood Disorder Drug - Benzinga
Royalty Pharma (RPRX) Crossed Above the 20-Day Moving Average: What That Means for Investors - Yahoo Finance
Royalty Pharma (NASDAQ:RPRX) Hits Perfect Technical Rating with Breakout Setup - ChartMill
Royalty Pharma (RPRX) files to potentially sell 11.9M Class A shares - Stock Titan
RPRX (RPRX) investor files to sell 125,000 Class A shares on NASDAQ - Stock Titan
Zealand gains $100M in funding from Royalty Pharma (RPRX:NASDAQ) - Seeking Alpha
Royalty Pharma and Zealand Pharma enter into rusfertide funding agreement for $100 million - The Manila Times
Zealand Pharma sells rusfertide royalty rights for $100 million - Investing.com
Zealand Pharma sells rusfertide royalty rights for $100 million By Investing.com - Investing.com UK
Behavioral Patterns of RPRX and Institutional Flows - Stock Traders Daily
Royalty Pharma plc and Zealand Pharma A/S Enter into Rusfertide Funding Agreement for $100 Million - marketscreener.com
Zealand Pharma enters into a USD 100 million royalty purchase and sale agreement with Royalty Pharma for the economics related to rusfertide - The Manila Times
Royalty Pharma PLC (NASDAQ:RPRX) Plans Quarterly Dividend of $0.23 - MarketBeat
Royalty Pharma (RPRX) Q2 2026 Earnings Call Transcript - AOL.com
Royalty Pharma PLC $RPRX Shares Sold by Wedge Capital Management L L P NC - MarketBeat
Royalty Pharma PLC $RPRX Stake Boosted by Handelsbanken Fonder AB - MarketBeat
How Royalty Pharma’s Stronger H1 2026 Earnings and New Academic Focus At Royalty Pharma (RPRX) Has Changed Its Investment Story - webull.com
Should Income Investors Look At Royalty Pharma plc (NASDAQ:RPRX) Before Its Ex-Dividend? - webull.com
Royalty Pharma publishes transcript of Q2 2026 financial results call - Bitget
A3LZUK Bond Profile — Key Metrics - TradingView
A3LZUK Bond Coupon Profile — Rate & Payments - TradingView
Royal Bank of Canada Purchases 23,479 Shares of Royalty Pharma PLC $RPRX - MarketBeat
RPHC5824520 Bond Risk Profile - TradingView
Royalty Pharma (NASDAQ:RPRX) Lowered to "Buy" Rating by Wall Street Zen - MarketBeat
Royalty Pharma (RPRX) CEO gets share award and gifts partnership interests - Stock Titan
Royalty Pharma plc (RPRX) CFO logs equity award and 18,500-share gift - Stock Titan
Royalty Pharma (NASDAQ: RPRX) EVP gets 11,002-share Class A equity award - Stock Titan
Royalty Pharma (RPRX) EVP gets 8,252 shares, gifts LP interests - Stock Titan
Royalty Pharma plc (RPRX) Stock Forecasts - Yahoo! Finance Canada
JPMorgan Chase & Co. Issues Positive Forecast for Royalty Pharma (NASDAQ:RPRX) Stock Price - MarketBeat
Royalty Pharma PLC (RPRX) Stock News Today - TradingKey
Bank of America Corp DE Buys 786,921 Shares of Royalty Pharma PLC $RPRX - MarketBeat
Royalty Pharma (NASDAQ:RPRX) Announces Earnings Results, Misses Expectations By $1.23 EPS - MarketBeat
Royalty Pharma Q2 2026 slides: guidance raised on strong growth - Investing.com
Royalty Pharma Q2 Earnings Call Highlights - MarketBeat
Royalty Pharma PLC (RPRX) (Q2 2026) Earnings Call Highlights: Strong Growth and Raised Guidance - Yahoo Finance
BofA raises Royalty Pharma stock price target on strong results By Investing.com - Investing.com South Africa
BofA raises Royalty Pharma stock price target on strong results - Investing.com
Earnings call transcript: Royalty Pharma lifts 2026 outlook in strong Q2 - Investing.com
Royalty Pharma plc 2026 Q2ResultsEarnings Call Presentation (NASDAQ:RPRX) 2026-08-05 - Seeking Alpha
Royalty Pharma PLC reports results for the quarter ended June 30Earnings Summary - TradingView
Royalty Pharma (RPRX) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance
Royalty Pharma plc 2026: Revenue $674.14M, EPS $0.04— 10-Q Summary - TradingView
Royalty Pharma (Nasdaq: RPRX) lifts H1 2026 cash flow and profit - Stock Titan
Royalty Pharma (RPRX) Tops Q2 Earnings and Revenue Estimates - Yahoo Finance
21.96%
0.62%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):